DA
AHCO icon

Denali Advisors’s AdaptHealth AHCO Stock Holding History

Denali Advisors’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-285
Closed -$3.28K – 183
2024
Q1 		$3.28K Sell
285
-37
-11% -$314 ﹤0.01% 377
2023
Q4 		$2.35K Buy
322
+86
+36% +$678 ﹤0.01% 391
2023
Q3 		$2.15K Buy
+236
New +$2.83K ﹤0.01% 412

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Denali Advisors's AHCO Position: Q2 2024 in Review

Denali Advisors sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 285 shares — an estimated $3.28K sold.

Denali Advisors first reported a position in AHCO in Q3 2023 and held it in 3 quarters. The position peaked at $3.28K in Q1 2024. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • Denali Advisors reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 285 AdaptHealth shares in Q2 2024, an estimated $3.28K.
  • Denali Advisors first reported a position in AdaptHealth in Q3 2023 and held it in 3 quarters.
  • Denali Advisors's AdaptHealth position peaked at $3.28K in Q1 2024.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.